PINK:DTCFF

Defence Therapeutics Stock Forecast

etoro logo Buy DTCFF
*Your capital is at risk
$0.323
-0.0081 (-2.44%)
At Close: Jul 10, 2026
AI Analysis AI Analysis of DTCFF AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add DTCFF to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Defence Therapeutics Inc stock price ended at $0.323 on Friday, after losing 2.44%
(Updated on Jul 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 09, 2026 Loss -2.44%

The Defence Therapeutics Inc stock price fell by -2.44% on the last day (Friday, 10th Jul 2026) from $0.332 to $0.323. During the last trading day the stock fluctuated 2.02% from a day low at $0.317 to a day high of $0.323. The price has fallen in 4 of the last 10 days and is down by -8.16% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -17 thousand shares and in total, 500 shares were bought and sold for approximately $161.73 .

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -16.02% during the next 3 months and, with a 90% probability hold a price between $0.232 and $0.367 at the end of this 3-month period.

DTCFF Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 30, 2026, and so far it has risen 10.77%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Defence Therapeutics Inc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.357. On a fall, the stock will find some support from the short-term average at $0.311. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Defence Therapeutics Inc stock

Defence Therapeutics Inc finds support from accumulated volume at $0.317 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0064 between high and low, or 2.02%. For the last week the stock has had daily average volatility of 2.93%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (DTCFF) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Defence Therapeutics Inc to open at $0.321, and during the day (based on 14 day Average True Range), to move between $0.311 and $0.336, which gives a possible trading interval of +/-$0.0245 (+/-7.87%) up or down from last closing price. If Defence Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 7.87% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.317 (1.87%) than the resistance at $0.350 (8.21%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Defence Therapeutics Inc stock A Buy?

Defence Therapeutics Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.888 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $0.321 ( 0.661%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

DTCFF Performance

Trading levels for DTCFF

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.328 1.32%
R2 0.325 0.564%
R1 0.324 0.0964%
Price 0.323
S1 0.319 -1.42%
S2 0.317 -1.89%
S3 0.315 -2.64%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.377 16.43%
R2 0.370 14.39%
R1 0.350 8.21%
Price 0.323
S1 0.317 -1.87%
S2 0.302 -6.73%
S3 0.300 -7.25%

FAQ

What is the symbol for Defence Therapeutics Inc Stock and on which exchange is it traded?
The symbol for Defence Therapeutics Inc is DTCFF and it is traded on the PINK (Pink Sheets).

Should I buy or sell Defence Therapeutics Inc Stock?
Defence Therapeutics Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Defence Therapeutics Inc Stock?
Defence Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Defence Therapeutics Inc Stock.

What's the current price of Defence Therapeutics Inc Stock?
As of the end of day on the Jul 10, 2026, the price of an Defence Therapeutics Inc (DTCFF) share was $0.323.

What is the 52-week high and low for Defence Therapeutics Inc Stock?
The 52-week high for Defence Therapeutics Inc Stock is $0.779 and the 52-week low is $0.292.

What is the market capitalization of Defence Therapeutics Inc Stock?
As of the Jul 10, 2026, the market capitalization of Defence Therapeutics Inc is 19.103M.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE